Ertiprotafib, also known as PTP-112, is a Protein Tyrosine Phosphatase 1B Inhibitor (PTP1B inhibitor). Ertiprotafib normalized the plasma glucose and insulin levels in diabetic animal models, and progressed to a phase II clinical trial. Ertiprotafib is potentially useful for the treatment of Non-Insulin Dependent Diabetes. Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms. Ertiprotafib is also a potent inhibitor of IkappaB kinase beta (IKK-beta), with an IC(50) of 400nM.
仅供研究使用。 我们不向患者出售。
化学信息
| 名称 | Ertiprotafib |
| Iupac 化学名称 | (2R)-2-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thiophen-4-yl)-2,6-dimethylphenoxy)-3-phenylpropionic acid |
| 同义词 | PTP-112; PTP112; PTP 112 |
| 英文同义词 | PTP-112; PTP112; PTP 112 |
| 分子式 | C31H27BrO3S |
| 分子量 | 559.52 |
| Smile | BrC1=C2C=CC=CC2=C(C2=C1SC(=C2C)C)C2=CC(=C(O[C@@H](C(=O)O)CC1=CC=CC=C1)C(=C2)C)C |
| InChiKey | FONCZICQWCUXEB-RUZDIDTESA-N |
| InChi | InChI=1S/C31H27BrO3S/c1-17-14-22(15-18(2)29(17)35-25(31(33)34)16-21-10-6-5-7-11-21)27-23-12-8-9-13-24(23)28(32)30-26(27)19(3)20(4)36-30/h5-15,25H,16H2,1-4H3,(H,33,34)/t25-/m1/s1 |
| Cas号 | 251303-04-5 |
| 相关CAS号 | |
| 外观性状 | crystalline solid |
| 纯度 | 98% |
| 存储 | 3 years -20ºCpowder |
| 可溶性 | Soluble in DMSO |
| 处理方式 | |
| 运输条件 | Shipped under ambient temperature as non-hazardous chemical. |
| 海关编码 | |
| Targets | |
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study | |